Guidance on Patient Involvement

Patient organisations, academia, not-for-profit organizations, and pharmaceutical companies, HTA and regulatory bodies are represented in the EUPATI partnership. Together, through reviews and a process of public consultation, sets of policies and standards for patient's involvement in medicines research and development have been published. These guidance should be used in relevant stakeholder communities and will contribute to the development of internal operating procedures in organizations and companies.

See guidance documents